PRESS
PRESS RELEASES
Neuroplasticity Alliance Welcomes Dr. Martin M. Bednar as Chair of Scientific Advisory Board
Neuroplasticity Alliance accelerates awareness and access to advances in neuroscience that have the potential to change the trajectory of life for the 50% of the population that has neurological challenges.
​
Atlanta, GA / August 14, 2025 - The Neuroplasticity Alliance (NPA) is proud to announce the appointment of Martin M. Bednar, M.D., Ph.D., FAANS, as Chair of its Scientific Advisory Board (SAB), effective September 1, 2025. A globally recognized leader in neuroscience, Dr. Bednar brings over three decades of clinical, academic, and industry experience to lead the development and strategy of NPA’s SAB.
Neuroplasticity Alliance Welcomes Renowned Stroke Recovery Pioneer Dr. Seth P. Finklestein to Scientific Advisory Board
.png)
LOUISVILLE, KY – May 22, 2026 — The Neuroplasticity Alliance (NPA), a leading nonprofit organization dedicated to bridging the gap between cutting-edge neurological research and mainstream clinical care, today announced the appointment of Dr. Seth P. Finklestein, MD, to its Scientific Advisory Board. Dr. Finklestein, a world-renowned Neurologist and an authority on ischemic stroke recovery, brings more than five decades of paradigm-shifting academic and clinical experience to NPA.
Neuroplasticity Alliance Announces Launch to Accelerate Transformative Treatment Approach for Brain Dysfunction
Neuroplasticity Alliance is working to remove the barriers stalling a paradigm shift towards recovery versus treating symptoms.
​
Atlanta, GA / April 28, 2020 - The Neuroplasticity Alliance (NPA) today announces the launch of a new not-for-profit focused on accelerating development of neuroplastic treatments and their integration into the healthcare system. These treatments target the root cause of neurologic disorders.